Depression and obstructive sleep apnea in patients with coronary heart disease

Robert M Carney1, William B Howells, Kenneth E Freedland

  • 1Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA. carneyr@bmc.wustl.edu

Insights

Major depression in coronary heart disease patients is linked to longer obstructive sleep apnea episodes, particularly in men. This finding highlights the connection between depression, sleep apnea, and cardiac risk.

Area of Science:

  • Cardiology
  • Sleep Medicine
  • Psychiatry

Background:

  • Depression is a known risk factor for cardiac events in patients with coronary heart disease (CHD).
  • Obstructive sleep apnea/hypopnea syndrome (OSAHS) frequently co-occurs with depression and is also a cardiac risk factor.
  • Undiagnosed OSAHS may contribute to the elevated cardiac risk observed in depressed individuals.

Purpose of the Study:

  • To investigate the relationship between depression severity and the presence and characteristics of OSAHS in patients with CHD.
  • To determine if OSAHS prevalence or severity differs among patients with major depression (MD), minor depression (md), and no depression (ND).

Main Methods:

  • Medically stable patients with CHD were categorized into MD (n=53), md (n=36), or ND (n=43) groups.
  • All participants underwent two nights of evaluation in a sleep medicine laboratory to assess for OSAHS.
  • Key metrics included the prevalence of OSAHS, frequency and duration of apneic/hypopneic episodes, and oxygen desaturations.

Main Results:

  • OSAHS prevalence did not significantly differ across depression groups (MD 66%, md 69%, ND 77%).
  • Patients with MD exhibited significantly more frequent and longer apneic/hypopneic episodes and greater oxygen desaturations compared to the md group.
  • While MD patients had longer apnea durations than ND patients, frequency of episodes and oxygen desaturations showed no significant difference between MD and ND groups, though gender-specific trends were noted.

Conclusions:

  • OSAHS is not more prevalent in depressed patients with CHD.
  • Major depression is associated with longer obstructive sleep apneic episodes in both male and female CHD patients.
  • Men with major depression showed a tendency towards a higher frequency of obstructive episodes compared to men without depression.
Abstract

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...